Literature DB >> 28239867

Inpatient cost analysis for treatment of myasthenia gravis.

Jacklyn O Omorodion1, Jesse M Pines2, Henry J Kaminski1.   

Abstract

INTRODUCTION: We explore trends in U.S. inpatient costs of care over a 10-year period.
METHODS: We compare myasthenia gravis (MG) with multiple sclerosis (MS) and overall U.S. hospital admissions using the Agency for Healthcare Research and Quality Nationwide Inpatient Sample database for 2003-2013.
RESULTS: Total costs of MG inpatient care rose 13-fold from 2003 to 2013. This was accounted for by a greater than sixfold increase in discharges and a greater than twofold increase in cost per discharge. The < 17 and >85 years age groups experienced the greatest increases in discharges. Medicare and Medicaid use increased. Regional variations in cost were apparent. There were greater rises in the Midwestern and Southern United States, which is dissimilar to MS and all hospital admissions. DISCUSSION: There was a dramatic and disproportionate rise in the number of MG discharges, most likely because of changes in practice patterns. Muscle Nerve 56: 1114-1118, 2017.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  healthcare costs; hospitalizations; multiple sclerosis; myasthenia gravis; practice patterns

Mesh:

Year:  2017        PMID: 28239867     DOI: 10.1002/mus.25624

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  2 in total

1.  Real-World Healthcare Resource Utilization and Cost Burden Assessment for Adults With Generalized Myasthenia Gravis in the United States.

Authors:  Glenn Phillips; Catarina Abreu; Amit Goyal; Yuebing Li; Albert Whangbo; Deborah Gelinas; Edward Brauer; Sankha Bhattacharya
Journal:  Front Neurol       Date:  2022-01-18       Impact factor: 4.003

2.  Incidence, mortality, and economic burden of myasthenia gravis in China: A nationwide population-based study.

Authors:  Jingshan Chen; De-Cai Tian; Chao Zhang; Zixiao Li; Yi Zhai; Yuwen Xiu; Hongqiu Gu; Hao Li; Yongjun Wang; Fu-Dong Shi
Journal:  Lancet Reg Health West Pac       Date:  2020-11-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.